Don’t Worry about the Drug Industry’s Profits When Considering a Waiver on COVID-19 Intellectual Property Rights
Luke Hawksbee, Martin McKee and Lawrence King
Luke Hawksbee, Martin McKee and Lawrence King
Gabor Scheiring, Aytalina Azarova, Darja Irdam, Katarzyna Doniec, Martin McKee, David Stuckler and Lawrence King
Michael Ash, Lawrence King, Elias Nosrati, Jacob Kang-Brown and Martin McKee